Real-Life Wear Time and Reasons for Reduced Wear Time of Glucose Sensors of CGM Systems: Findings from the DiaLink Panel.

Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DE reports Advisory Board member fees from Dexcom Germany and Roche Diabetes Care as well as honoraria for lectures from Berlin Chemie AG, Sanofi-Aventis, Dexcom Germany, Boehringer Ingelheim, Eli Lilly, and Roche Diabetes Care. BO reports Advisory Board member fees from Abbott Diabetes Care as well as honoraria for lectures from Astra Zeneca, Eli Lilly and Evivamed. TR reports honoraria for lectures from Berlin Chemie AG. NH reports Advisory Board member fees from Abbott Diabetes Care and Insulet as well as honoraria for lectures from Berlin Chemie AG, Becton Dickenson, Sanofi Germany, Roche Diabetes Care, and Dexcom Germany. BK reports Advisory Board member fees from Abbott Diabetes Care, Embecta, Roche Diabetes Care, Novo Nordisk, Berlin Chemie AG, and Dexcom Germany as well as honoraria for lectures from Sanofi Germany, Novo Nordisk, Abbott Diabetes Care, Roche Diabetes Care, Berlin Chemie AG, Embecta, Dexcom, and Feen. In addition, he reports support for travel and fees for scientific meetings from Sanofi, Roche Diabetes Care and Berlin Chemie AG as well as unpaid obligations as workshop leader and member of working groups of the German Diabetes Association. LH is a consultant for Abbott, Lifecare (also a member of the Board of Directors), Medtronic EU Advisory Board, Dexcom Germany, Roche Diagnostics, Liom, and Perfood. He is part owner of the Profil Institut für Stoffwechselforschung in Neuss, Germany, Science Consulting in Diabetes GmbH, Düsseldorf, Germany, and diateam GmbH, Bad Mergentheim, Germany.